Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas.

Weaver KD, Yeyeodu S, Cusack JC, Baldwin AS, Ewend MG. Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas. J Neurooncol. 2003 Feb; 61(3):187-96.

View in: PubMed

subject areas

Adenoviridae
Antineoplastic Agents
Apoptosis
Camptothecin
Carboplatin
Carmustine
Drug Synergism
Glioma
Humans
I-kappa B Proteins
NF-kappa B
Repressor Proteins
Transcriptional Activation
Transfection
Tumor Cells, Cultured
Tumor Necrosis Factor-alpha

authors with profiles

Susan Yeyeodu

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support